Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bf5622752f7df8cfda862954eb1dde5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92dd81bdd0d10ed3bc7807859a083297 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-033 |
filingDate |
2001-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ae17c60835c8015d081f9f9e9e526cf |
publicationDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0188115-B1 |
titleOfInvention |
Transgenic caenorhabditis elegans model exhibiting a neuronal dysfunction |
abstract |
The invention concerns a transgenic nematode exhibiting a transgenic neuron dysfunction phenotype in the apparent absence of neuronal death. The invention also concerns the transgene responsible for said phenotype and methods for screening therapeutic targets and active compounds for treating polyglutamine expansion diseases. |
priorityDate |
2000-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |